| UniProt ID | UCHL1_HUMAN | |
|---|---|---|
| UniProt AC | P09936 | |
| Protein Name | Ubiquitin carboxyl-terminal hydrolase isozyme L1 | |
| Gene Name | UCHL1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 223 | |
| Subcellular Localization |
Cytoplasm . Endoplasmic reticulum membrane Lipid-anchor . About 30% of total UCHL1 is associated with membranes in brain. |
|
| Protein Description | Ubiquitin-protein hydrolase involved both in the processing of ubiquitin precursors and of ubiquitinated proteins. This enzyme is a thiol protease that recognizes and hydrolyzes a peptide bond at the C-terminal glycine of ubiquitin. Also binds to free monoubiquitin and may prevent its degradation in lysosomes. The homodimer may have ATP-independent ubiquitin ligase activity.. | |
| Protein Sequence | MQLKPMEINPEMLNKVLSRLGVAGQWRFVDVLGLEEESLGSVPAPACALLLLFPLTAQHENFRKKQIEELKGQEVSPKVYFMKQTIGNSCGTIGLIHAVANNQDKLGFEDGSVLKQFLSETEKMSPEDRAKCFEKNEAIQAAHDAVAQEGQCRVDDKVNFHFILFNNVDGHLYELDGRMPFPVNHGASSEDTLLKDAAKVCREFTEREQGEVRFSAVALCKAA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MQLKPMEI -------CCCCCCCC | 10.71 | - | |
| 4 | Acetylation | ----MQLKPMEINPE ----CCCCCCCCCHH | 25.98 | 7367441 | |
| 4 | Ubiquitination | ----MQLKPMEINPE ----CCCCCCCCCHH | 25.98 | 21906983 | |
| 15 | Ubiquitination | INPEMLNKVLSRLGV CCHHHHHHHHHHHCC | 40.36 | 21890473 | |
| 18 | Phosphorylation | EMLNKVLSRLGVAGQ HHHHHHHHHHCCCCC | 28.57 | 29978859 | |
| 38 | Phosphorylation | VLGLEEESLGSVPAP ECCCCHHHCCCCCHH | 41.11 | 25338102 | |
| 64 | Ubiquitination | AQHENFRKKQIEELK HCCCCHHHHHHHHHC | 44.91 | - | |
| 65 | Ubiquitination | QHENFRKKQIEELKG CCCCHHHHHHHHHCC | 52.86 | 17259170 | |
| 65 | Malonylation | QHENFRKKQIEELKG CCCCHHHHHHHHHCC | 52.86 | 26320211 | |
| 71 | Ubiquitination | KKQIEELKGQEVSPK HHHHHHHCCCCCCHH | 62.92 | - | |
| 71 | Malonylation | KKQIEELKGQEVSPK HHHHHHHCCCCCCHH | 62.92 | 26320211 | |
| 78 | Ubiquitination | KGQEVSPKVYFMKQT CCCCCCHHHEEEECC | 41.90 | 21890473 | |
| 78 | Acetylation | KGQEVSPKVYFMKQT CCCCCCHHHEEEECC | 41.90 | 26210075 | |
| 80 | Nitration | QEVSPKVYFMKQTIG CCCCHHHEEEECCCC | 12.23 | - | |
| 83 | Ubiquitination | SPKVYFMKQTIGNSC CHHHEEEECCCCCCC | 34.10 | 21906983 | |
| 89 | Phosphorylation | MKQTIGNSCGTIGLI EECCCCCCCHHHHHH | 14.54 | 20068231 | |
| 105 | Ubiquitination | AVANNQDKLGFEDGS HHHCCCCCCCCCCHH | 40.52 | - | |
| 112 | Phosphorylation | KLGFEDGSVLKQFLS CCCCCCHHHHHHHHH | 36.28 | 29514088 | |
| 115 | Ubiquitination | FEDGSVLKQFLSETE CCCHHHHHHHHHHHH | 36.53 | 21906983 | |
| 119 | Phosphorylation | SVLKQFLSETEKMSP HHHHHHHHHHHCCCH | 43.70 | - | |
| 123 | Ubiquitination | QFLSETEKMSPEDRA HHHHHHHCCCHHHHH | 52.69 | - | |
| 125 | Phosphorylation | LSETEKMSPEDRAKC HHHHHCCCHHHHHHH | 35.88 | - | |
| 131 | Malonylation | MSPEDRAKCFEKNEA CCHHHHHHHHHHHHH | 40.11 | 26320211 | |
| 132 | Glutathionylation | SPEDRAKCFEKNEAI CHHHHHHHHHHHHHH | 5.34 | 22555962 | |
| 135 | Ubiquitination | DRAKCFEKNEAIQAA HHHHHHHHHHHHHHH | 39.57 | 21906983 | |
| 152 | S-nitrosocysteine | AVAQEGQCRVDDKVN HHHHHCCCCCCCCEE | 7.23 | - | |
| 152 | Glutathionylation | AVAQEGQCRVDDKVN HHHHHCCCCCCCCEE | 7.23 | 22555962 | |
| 152 | S-nitrosylation | AVAQEGQCRVDDKVN HHHHHCCCCCCCCEE | 7.23 | 19483679 | |
| 157 | Ubiquitination | GQCRVDDKVNFHFIL CCCCCCCCEEEEEEE | 34.32 | 21906983 | |
| 179 | Sulfoxidation | LYELDGRMPFPVNHG EEEECCCCCCCCCCC | 4.99 | 30846556 | |
| 188 | Phosphorylation | FPVNHGASSEDTLLK CCCCCCCCCHHHHHH | 38.56 | 20068231 | |
| 189 | Phosphorylation | PVNHGASSEDTLLKD CCCCCCCCHHHHHHH | 38.67 | 20068231 | |
| 192 | Phosphorylation | HGASSEDTLLKDAAK CCCCCHHHHHHHHHH | 29.91 | 20068231 | |
| 195 | Acetylation | SSEDTLLKDAAKVCR CCHHHHHHHHHHHHH | 48.73 | 19608861 | |
| 195 | Ubiquitination | SSEDTLLKDAAKVCR CCHHHHHHHHHHHHH | 48.73 | 19608861 | |
| 215 | Phosphorylation | EQGEVRFSAVALCKA HCCCEEEEEEHHHHC | 15.98 | 27732954 | |
| 220 | Farnesylation | RFSAVALCKAA---- EEEEEHHHHCC---- | 1.71 | 19261853 | |
| 220 | S-nitrosocysteine | RFSAVALCKAA---- EEEEEHHHHCC---- | 1.71 | - | |
| 220 | S-nitrosylation | RFSAVALCKAA---- EEEEEHHHHCC---- | 1.71 | 19483679 | |
| 220 | Farnesylation | RFSAVALCKAA---- EEEEEHHHHCC---- | 1.71 | 19261853 | |
| 221 | Ubiquitination | FSAVALCKAA----- EEEEHHHHCC----- | 48.47 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of UCHL1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of UCHL1_HUMAN !! | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| Prenylation | |
| Reference | PubMed |
| "Membrane-associated farnesylated UCH-L1 promotes alpha-synucleinneurotoxicity and is a therapeutic target for Parkinson's disease."; Liu Z., Meray R.K., Grammatopoulos T.N., Fredenburg R.A.,Cookson M.R., Liu Y., Logan T., Lansbury P.T. Jr.; Proc. Natl. Acad. Sci. U.S.A. 106:4635-4640(2009). Cited for: SUBCELLULAR LOCATION, AND ISOPRENYLATION AT CYS-220. | |